Recalls from Unichem Pharmaceuticals USA Inc.

• Unichem busPIRone Hydrochloride Tablets (opens in a new tab)
  Low risk, FDA, May 1, 2026, Wrong drug strength
• Unichem Doxazosin Tablets (opens in a new tab)
  Low risk, FDA, Feb 11, 2026, Labeling error
• Unichem Bisoprolol Fumarate and Hydrochlorothiazide Tablets (opens in a new tab)
  Moderate risk, FDA, Jan 30, 2026, Drug impurity

Data: Recall Canary (opens in a new tab)